| Literature DB >> 18496262 |
Allan Gibofsky1, Robert L Barkin.
Abstract
Chronic/persistent pain due to osteoarthritis is one of the most common pain conditions affecting Americans today. Inadequate pain relief or dissatisfaction with current treatments is a source of frustration and suffering for patients with chronic/persistent pain. The requirement of multiple doses of commonly used analgesics to maintain adequate pain relief is inconvenient for many patients with osteoarthritis-related chronic pain. The several extended-release opioid analgesics that have been developed may provide an opportunity for improved patient convenience; however, clinicians must consider adverse event profiles, pharmacokinetics, abuse potential, and controlled substance-scheduling status of extended-release opioid analgesics. The purpose of this review is to highlight the efficacy and safety of extended-release opioid analgesics utilized in the management plan of chronic pain due to osteoarthritis.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18496262 DOI: 10.1097/MJT.0b013e3181727f68
Source DB: PubMed Journal: Am J Ther ISSN: 1075-2765 Impact factor: 2.688